MU OPIOID RECEPTOR GENE IN HEROIN ADDICTS

海洛因成瘾是一个主要的社会问题，影响着美国100多万人。 在身体和大脑中，海洛因被水解为吗啡，吗啡作用于μ阿片受体并产生欣快效应，从而赋予药物的增强特性并促成成瘾。药物成瘾是一个复杂的过程，被认为是社会、环境和生物因素（包括遗传因素）相互作用的结果。 在我们最初的提议中，我们假设基因多态性可能存在于μ阿片受体中并改变受体功能，从而导致个体对海洛因滥用的易感性变化。 在目前的资助期间，我们观察到五种不同的单核苷酸多态性（SNPs）;其中两种SNPs相对常见（10.5%和6.6%等位基因频率），并且都显示出种族群体之间的差异分布。 其中一种似乎在一个种族群体中对阿片类药物成瘾产生保护作用;它还改变了β-内啡肽结合亲和力和激动剂效力。 另一种常见的变异在前海洛因成瘾者中发生的频率明显更高，表明阿片类药物依赖的遗传倾向。在这个竞争性的更新申请中，我们建议扩展我们对人类μ阿片受体遗传变异的临床和功能意义的研究。 我们将检查大量的研究对象，并确定等位基因分布在前海洛因成瘾者和控制之间的不同种族群体。 我们还将研究它们对神经元Ca 2+通道受体调节和腺苷酸环化酶活性抑制的影响。 此外，我们将确定μ受体多态性对慢性吗啡治疗的细胞反应的影响，因为海洛因成瘾期间出现的主要问题来自长期暴露于阿片类药物。本次更新申请中拟议研究的结果将在两个领域提供有价值的信息：首先，通过研究序列变异对mu受体细胞功能的影响，我们将了解遗传多态性如何影响受体活性和神经元兴奋性。 此外，通过确定阿片类药物依赖个体和正常对照之间这些遗传变异的分布，我们将开始认识到遗传多态性的作用是易感性或对阿片类药物依赖的保护。

Addiction to heroin is a major social problem, affecting over a million people in the United States. In the body and brain, heroin is hydrolyzed to morphine, which acts at the mu opioid receptor and results in a euphoric effect, thus conferring the reinforcing properties of the drug and contributing to addiction. Drug addiction is a complex process, thought to result from the interaction of social, environmental, and biological factors including a genetic component. In our original proposal, we hypothesized that genetic polymorphisms might exist in the mu opioid receptor and alter receptor function, contributing to variation in individual susceptibility to heroin abuse. During the current funding period we have observed five different single nucleiotide polymorphisms (SNPs); two of these SNPs were relatively common (10.5 percent and 6.6 percent allelic frequency), and both showed differential distributions among ethnic groups. One appeared to exert a protective effect against opioid addiction in one of the ethnic groups; it also altered beta-endorphin binding affinity and agonist potency. The other common variant occurred with a significantly higher frequency in former heroin addicts, suggesting a genetic predisposition for opioid dependence. In this competing renewal application, we propose to extend our study of the clinical and functional significance of genetic variation in the human mu opioid receptor. We will examine a larger number of study subjects, and determine the allele distribution in former heroin addicts and controls among different ethnic groups. We will also examine their impact on receptor modulation of neuronal Ca2+ channels and inhibition of adenylyl cyclase activity. Furthermore, we will determine the effects of the mu receptor polymorphisms on the cellular responses to chronic morphine treatment, since the primary problems that develop during heroin addiction come from prolonged exposure to the opioid drug. Results from the proposed study in this renewal application will provide valuable information in two areas: First of all, by studying the effects of sequence variants on the cellular function of the mu receptor, we will understand how genetic polymorphisms impact on receptor activity and neuronal excitability. Furthermore, by determining distribution of these genetic variations between opioid-dependent individuals and normal controls, we will start to appreciate the role of genetic polymorphism is predisposition for or protection against opioid dependence.